By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Coremed, Inc. 

Chicago  Illinois    U.S.A.
Phone: n/a Fax:




Company News
Coremed, Inc. Introduces IVE(TM), A Proprietary Drug-Delivery Platform Technology That Improves Protein Absorption Within The Gastrointestinal Tract 11/14/2005 1:06:00 PM
Coremed, Inc. To Raise Funds And Structure Strategic Alliances For Developing Inhalable And Oral Insulin-Delivery Systems10/19/2005 5:11:35 PM
Coremed, Inc. Announces Major Breakthrough In Development Of Alvair(TM), Pulmonary-Delivered Insulin, Based On Animal Study10/19/2005 5:10:15 PM
Based On Pre-Clinical Data, Coremed, Inc.'s Alveair Insulin(TM) Achieves Better Insulin Bioavailability Than Intravenous Injection Of Analog Insulin10/19/2005 5:09:56 PM
Coremed, Inc., Announces Positive Data From First Human Trial Of Alveair(TM) Insulin Pulmonary Technology10/19/2005 5:09:43 PM
Coremed, Inc. To Announce Human Trials Of Alveair(TM) Insulin Pulmonary Technology That Performs Like A "Needle-Less Syringe"10/19/2005 5:09:35 PM
Coremed, Inc. Signs Joint Venture With China's Major Pharmas To Develop Alveair(TM) Inhalable Insulin10/19/2005 5:09:10 PM